文献速递关节外科

初次全髋关节置换术中赋能技术的成本后果:倾向性匹配队列研究

Cost Consequences of Enabling Technologies in Primary Total Hip Arthroplasty: A Propensity Matched Cohort Study.
PubMed 文献 · J Arthroplasty · 2026-09-04

该回顾性倾向性匹配队列研究比较了2019至2023年间513对技术辅助与手动初次全髋关节置换术的标准化诊疗周期成本。技术辅助组住院费用(17377 vs 16814美元,P<0.001)和90天术后费用(2661 vs 1440美元,P=0.013)均更高,导致总诊疗周期成本更高(20038 vs 18255美元,P<0.001),尽管住院时间略有缩短(1.1 vs 1.2天,P=0.004)。

要点

  • 技术辅助初次全髋关节置换术的住院、90天术后及总诊疗周期成本均显著高于手动技术。
  • 各技术亚组均显示成本增加,手持导航和图像机器人辅助的总诊疗周期成本也更高。
  • 技术辅助组住院时间仅轻微缩短,未观察到术后成本的补偿性降低。

核心结论

  • 与手动技术相比,技术辅助初次全髋关节置换术与住院和90天诊疗周期成本的适度增加相关。
  • 尽管住院时间略有缩短,但未观察到术后成本的补偿性降低。

研究设计与样本

  • 回顾性、倾向性匹配队列研究,使用机构全关节登记数据,比较2019至2023年间技术辅助与手动初次全髋关节置换术的标准化诊疗周期成本。
  • 513例技术辅助全髋关节置换术按年龄、性别、体重指数、手术年份、股骨头尺寸/材料、手术入路和植入物构造与手动全髋关节置换术进行1:1匹配。

主要发现

  • 技术辅助组住院费用为17377美元,手动组为16814美元(P<0.001)。
  • 技术辅助组90天术后费用为2661美元,手动组为1440美元(P=0.013)。
  • 技术辅助组总诊疗周期费用为20038美元,手动组为18255美元(P<0.001)。
  • 技术辅助组住院时间为1.1天,手动组为1.2天(P=0.004)。
  • 亚组分析显示所有技术类型成本均增加,手持导航和图像机器人辅助的总诊疗周期成本也更高。

关键数值与推荐

  • 成本 Outcomes 包括住院费用、90天术后费用和总诊疗周期费用,使用Medicare成本-收费比率和报销率计算。
  • 赋能技术的资本购置和服务费用被排除在外。

临床怎么用

  • 临床采用技术辅助初次全髋关节置换术时需考虑其与手动技术相比的适度成本增加,尽管住院时间略有缩短。
  • 在技术使用扩大背景下,需进一步评估成本效益和更广泛的临床获益。

局限性

  • 资本购置和服务费用被排除,可能低估技术辅助的真实经济影响。
  • 回顾性设计及单机构登记数据可能限制普适性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The use of enabling technologies, including handheld navigation, fluoroscopic-assisted navigation, and image-based robotics, in primary total hip arthroplasty (THA) has increased markedly in recent years. Although surgeons and institutions adopt these guidance systems for diverse reasons, their economic impact remains incompletely defined. The present study compared standardized episode-of-care costs for technology-assisted and manual THA, encompassing both index hospitalization and 90-day postoperative expenditures. METHODS: A retrospective, propensity-matched cohort study was conducted using our institutional total joint registry to compare standardized episode-of-care costs for technology-assisted versus manual primary THA performed between 2019 and 2023. There were 513 technology-assisted THAs matched 1:1 to manual THAs based on age, sex, body mass index, year of surgery, femoral head size/material, surgical approach, and implant construct. Cost outcomes included index hospitalization cost, 90-day postoperative cost, and total episode-of-care cost, calculated using Medicare cost-to-charge ratios and reimbursement rates. Capital acquisition and service fees for enabling technologies were excluded. RESULTS: Technology-assisted THA was associated with higher index procedure costs ($17,377 versus $16,814; P < 0.001) and higher 90-day postoperative costs ($2,661 versus $1,440; P = 0.013), resulting in greater episode-of-care costs ($20,038 versus $18,255; P < 0.001). Subgroup analyses showed increased costs across all technology types, with handheld navigation and image-based robotics also demonstrating higher total episode-of-care costs. Lengths of stay were slightly reduced in the technology-assisted cohort (1.1 versus 1.2 days; P = 0.004). CONCLUSION: Technology-assisted THA was associated with modest increases in index and 90-day episode-of-care costs compared with manual techniques. Although lengths of stay were marginally reduced, no compensatory reduction in postoperative costs was observed. While surgeons and hospitals adopt technology for diverse reasons, further evaluation of cost-effectiveness and broader clinical benefits is warranted as the use of enabling technologies expands.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Williams JL, Gonzalez-Bravo AE, Moriarty JP, et al. Cost Consequences of Enabling Technologies in Primary Total Hip Arthroplasty: A Propensity Matched Cohort Study. J Arthroplasty. 2026. PMID: 42697452. doi:10.1016/j.arth.2026.08.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。